Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.80 |
| ▸ | CA1 | P00915 | 4/20 | 0.80 |
| ▸ | CA2 | P00918 | 4/20 | 0.80 |
| ▸ | CA9 | Q16790 | 4/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.80 |
| ▸ | CA3 | P07451 | 3/20 | 0.80 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.80 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.80 |
| ▸ | CA4 | P22748 | 2/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.80 |
| ▸ | NPC1 | O15118 | 1/20 | 0.80 |
| ▸ | GMNN | O75496 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 1/20 | 0.80 |
| ▸ | TYR | P14679 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL28468106 | 0.90 | CA2 (0.80) | CA12CA1CA2CA9ALOX15 | |
| Hydroquinone SCHEMBL11511669 | 0.89 | ALOX15 (1.00) | CA12CA1CA2CA9ALOX15 | |
| Hydroquinone SCHEMBL15516 | 0.89 | — | — | |
| Hydroquinone SCHEMBL460669 | 0.89 | ALOX15 (1.00) | CA12CA1CA2CA9ALOX15 | |
| Hydrazine SCHEMBL29067366 | 0.88 | ESR1 (0.85) | CA12CA1CA2CA9ALOX15 | |
| Hydroquinone SCHEMBL27813899 | 0.86 | CYP3A4 (0.73) | CA12CA1CA2CA9ALOX15 | |
| Hydroquinone SCHEMBL6259933 | 0.86 | CYP3A4 (0.73) | CA12CA1CA2CA9ALOX15 | |
| Hydroquinone SCHEMBL11758857 | 0.86 | CYP3A4 (0.73) | CA12CA1CA2CA9ALOX15 | |
| Hydroquinone SCHEMBL8680894 | 0.84 | — | — | |
| Hydroquinone SCHEMBL11552027 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158351-A1 | S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS | XAVIER UNIVERSITY OF LOUISIANA | 2024-05-16 | — | — | US | disclosed |
| US-11912660-B2 | S6K1 protein kinase inhibitors as cancer therapeutics | XAVIER UNIVERSITY OF LOUISIANA (US) | 2024-02-27 | — | — | US | disclosed |
| US-20210323919-A1 | S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS | XAVIER UNIVERSITY OF LOUISIANA | 2021-10-21 | — | — | US | disclosed |
| US-7074959-B2 | Methods and systems for remediating hydrazine-contaminated equipment and/or surfaces | NEW MEXICO HIGHLANDS UNIVERSITY (US) | 2006-07-11 | — | — | US | disclosed |
| US-6955706-B2 | Liquid degassing system for power plant system layup | DOMINION ENGINEERING INC (US) | 2005-10-18 | — | — | US | disclosed |
| US-20040025696-A1 | Liquid degassing system for power plant system layup | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2004-02-12 | — | — | US | disclosed |
| US-20040024251-A1 | Methods and systems for hydrazine remediation | HELVENSTON MERRITT C (US) | 2004-02-05 | — | — | US | disclosed |
| WO-2003086573-A1 | LIQUID DEGASSING SYSTEM FOR POWER PLANT SYSTEM LAYUP | DOMINION ENGINEERING, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323919-A1 | S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS | RPS6KA6, RPS6KA1, RPS6KA3 | CA12 4718/4885CA1 4839/4885CA2 4437/4885 |
| US-11912660-B2 | S6K1 protein kinase inhibitors as cancer therapeutics | RPS6KA6, RPS6KA1, RPS6KA3 | CA12 4718/4885CA1 4839/4885CA2 4437/4885 |
| US-20240158351-A1 | S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS | RPS6KA6, RPS6KA1, RPS6KA3 | CA12 4718/4885CA1 4839/4885CA2 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.